Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hallett, Penelope J
and
Standaert, David G
2004.
Rationale for and use of NMDA receptor antagonists in Parkinson's disease.
Pharmacology & Therapeutics,
Vol. 102,
Issue. 2,
p.
155.
Albensi, Benedict C.
Ata, Gabrielle
Schmidt, Erin
Waterman, Joseph D.
and
Janigro, Damir
2004.
Activation of long-term synaptic plasticity causes suppression of epileptiform activity in rat hippocampal slices.
Brain Research,
Vol. 998,
Issue. 1,
p.
56.
Hadj Tahar, Abdallah
Grégoire, Laurent
Darré, Aurélie
Bélanger, Nancy
Meltzer, Leonard
and
Bédard, Paul J
2004.
Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
Neurobiology of Disease,
Vol. 15,
Issue. 2,
p.
171.
Pollack, Alexia E.
St. Martin, Jessie L.
and
Macpherson, Alexa T.
2005.
Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
Synapse,
Vol. 56,
Issue. 1,
p.
45.
Galvan, A.
Kuwajima, M.
and
Smith, Y.
2006.
Glutamate and GABA receptors and transporters in the basal ganglia: What does their subsynaptic localization reveal about their function?.
Neuroscience,
Vol. 143,
Issue. 2,
p.
351.
Rammsayer, Thomas H.
2006.
Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance.
Brain Research,
Vol. 1073-1074,
Issue. ,
p.
407.
Balea, Ioan A.
Illes, Peter
and
Schober, Ralf
2006.
Affinity of corpora amylacea for oligonucleotides: Sequence dependency and proteinaceous binding motif.
Neuropathology,
Vol. 26,
Issue. 4,
p.
277.
2007.
Wiley Handbook of Current and Emerging Drug Therapies.
Samadi, Pershia
Rouillard, Claude
Bédard, Paul J.
and
Di Paolo, Thérèse
2007.
Parkinson's Disease and Related Disorders, Part I.
Vol. 83,
Issue. ,
p.
19.
Rao, Jayaraman
2007.
Parkinson's Disease and Related Disorders, Part I.
Vol. 83,
Issue. ,
p.
153.
Beste, Christian
Saft, Carsten
Güntürkün, Onur
and
Falkenstein, Michael
2008.
Increased Cognitive Functioning in Symptomatic Huntington's Disease As Revealed by Behavioral and Event-Related Potential Indices of Auditory Sensory Memory and Attention.
The Journal of Neuroscience,
Vol. 28,
Issue. 45,
p.
11695.
Rousseaux, Colin G.
2008.
A Review of Glutamate Receptors II: Pathophysiology and Pathology.
Journal of Toxicologic Pathology,
Vol. 21,
Issue. 3,
p.
133.
Tsirogiannis, George L.
Sakas, Damianos
Tagaris, George A.
and
Nikita, Konstantina S.
2009.
The role of synaptic parameters in a parkinsonian population level model of the basal ganglia.
p.
581.
Tsirogiannis, George L.
Tagaris, George A.
Sakas, Damianos
and
Nikita, Konstantina S.
2010.
A population level computational model of the basal ganglia that generates parkinsonian local field potential activity.
Biological Cybernetics,
Vol. 102,
Issue. 2,
p.
155.
Nicolás, María Jesús
López-Azcárate, Jon
Valencia, Miguel
Alegre, Manuel
Pérez-Alcázar, Marta
Iriarte, Jorge
Artieda, Julio
and
Hashimoto, Kenji
2011.
Ketamine-Induced Oscillations in the Motor Circuit of the Rat Basal Ganglia.
PLoS ONE,
Vol. 6,
Issue. 7,
p.
e21814.
Cheng, Furong
Li, Xin
Li, Yaohua
Wang, Chaodong
Wang, Tao
Liu, Guangwei
Baskys, Andrius
Uéda, Kenji
Chan, Piu
and
Yu, Shun
2011.
α‐Synuclein promotes clathrin‐mediated NMDA receptor endocytosis and attenuates NMDA‐induced dopaminergic cell death.
Journal of Neurochemistry,
Vol. 119,
Issue. 4,
p.
815.
Contreras, Monica Sanchez
and
Cardozo-Pelaez, Fernando
2011.
Extracellular and Intracellular Signaling.
p.
247.
Fox, Susan H.
and
Brotchie, Jonathan M.
2011.
Parkinson's Disease.
p.
432.
Qiu, Mei-Hong
Chen, Michael C.
Huang, Zhi-Li
and
Lu, Jun
2014.
Neuronal activity (c-Fos) delineating interactions of the cerebral cortex and basal ganglia.
Frontiers in Neuroanatomy,
Vol. 8,
Issue. ,
Chakkarapani, Elavazhagan
Chau, Vann
Poskitt, Kenneth J.
Synnes, Anne
Kwan, Eddie
Roland, Elke
and
Miller, Steven P.
2016.
Low plasma magnesium is associated with impaired brain metabolism in neonates with hypoxic‐ischaemic encephalopathy.
Acta Paediatrica,
Vol. 105,
Issue. 9,
p.
1067.